AccuStem Sciences Limited Share · US00442Y1010 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AccuStem Sciences Limited
No Price
Company Profile for AccuStem Sciences Limited Share
Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.
Company Data
Name AccuStem Sciences Limited
Company AccuStem Sciences Limited
Website
https://www.accustem.com
Primary Exchange 
UTC
UTC
ISIN US00442Y1010
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
Country United Kingdom
Currency USD
Employees -
Address 107 Cheapside, EC2V 6DN London
IPO Date 2021-07-21
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ACMSY |
More Shares
Investors who hold AccuStem Sciences Limited also have the following shares in their portfolio:
